| __timestamp | Bausch Health Companies Inc. | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 26684000 |
| Thursday, January 1, 2015 | 2682700000 | 29829000 |
| Friday, January 1, 2016 | 2810000000 | 39578000 |
| Sunday, January 1, 2017 | 2582000000 | 43277000 |
| Monday, January 1, 2018 | 2473000000 | 48645000 |
| Tuesday, January 1, 2019 | 2554000000 | 52934000 |
| Wednesday, January 1, 2020 | 2367000000 | 61349000 |
| Friday, January 1, 2021 | 2624000000 | 127125000 |
| Saturday, January 1, 2022 | 2625000000 | 136106000 |
| Sunday, January 1, 2023 | 2917000000 | 133175999 |
Cracking the code
In the competitive landscape of healthcare, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Bausch Health Companies Inc. and HUTCHMED (China) Limited, two giants in the industry, have shown contrasting approaches over the past decade. From 2014 to 2023, Bausch Health's SG&A expenses have consistently been higher, peaking at nearly $2.9 billion in 2023. In contrast, HUTCHMED's expenses have been significantly lower, reaching approximately $133 million in the same year. This stark difference highlights Bausch Health's larger scale of operations, but also raises questions about efficiency. While Bausch Health's expenses grew by about 44% over the period, HUTCHMED's increased by nearly 400%, indicating rapid expansion. Understanding these trends can provide valuable insights into each company's strategic priorities and operational efficiencies.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and HUTCHMED (China) Limited
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Viking Therapeutics, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
HUTCHMED (China) Limited and MannKind Corporation: SG&A Spending Patterns Compared